FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Cybersecurity Alert on Medtronic MiniMed Pump

FDA issues a safety alert on a cybersecurity risk with Medtronics MiniMed 600 Series Insulin Pump System (e.g., MiniMed 630G and MiniMed 670G).

latest-news-card-1
Federal Register

FDA Seeks Patient Advocates for Regulatory Forum

Federal Register notice: FDA seeks patient advocate applications to participate under its collaboration with the Clinical Trials Transformation Initia...

latest-news-card-1
Federal Register

Roches Endep Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Hoffmann-La Roches Endep (amitriptyline HCl) was not withdrawn from sale for safety or effectiveness reas...

latest-news-card-1
Medical Devices

FDA Clears New Roche cobas Diagnostic Platform

Roche gains FDA 510(k) clearance for the cobas pure integrated solutions, the next generation of its cobas diagnostics platform.

latest-news-card-1
Medical Devices

ClearPoint Neuro Navigation Software Cleared

FDA clears a ClearPoint Neuro 510(k) for its version 2.1 of the ClearPoint Neuro Navigation software.

latest-news-card-1
Human Drugs

Vanda Agrees to Pay Over $11 Million in Off-label Suit

Vanda Pharmaceuticals agrees to settle an off-label marketing case for $11.5 million.

latest-news-card-1
Human Drugs

Researcher Convicted in FDA False Statement Case

A federal jury convicts former clinical researcher for making a false statement to a government investigator related to her role in a clinical trial t...

latest-news-card-1
FDA General

DoJ Renews Individual Accountability Interest in Prosecutions

The Department of Justice says its top priority for corporate criminal enforcement is individual accountability by targeting the individuals who commi...

latest-news-card-1
Biologics

Pfizer Plans BLA for New Meningococcal Vaccine

Pfizer says it will file a BLA before year end for its pentavalent meningococcal vaccine (MenABCWY).

latest-news-card-1
Federal Register

FDA Panel to Discuss Kidney Disease Drug

Federal Register notice: FDA announces an 11/16 advisory committee meeting to discuss an Ardelyx NDA for tenapanor hydrochloride tablets.